Clinical trial

Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating…

NCT00066859 · Wake Forest University Health Sciences, Other · Completed

Key facts

NCT number NCT00066859
Title Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression
Official title A Phase III Double-Blind Randomized Trial Comparing Sertraline (Zoloft) And Hypericum Perforatum (St. John's Wort) In Cancer Patients With Mild To Moderate Depression
Lead sponsor Wake Forest University Health Sciences, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Depression, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Dietary Supplement, Drug
Interventions Zoloft 50 mg, St. John's Wort 600 mg
Enrollment 2
Start date Mar 1, 2004
Primary completion Apr 1, 2005
Completion Nov 1, 2005
First posted Aug 7, 2003
Last update posted Sep 9, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies